FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000838340> ?p ?o ?g. }

• W2000838340 endingPage "1241" @default.
• W2000838340 startingPage "1236" @default.
• W2000838340 abstract "Between 1978 and 1983, 1127 patients with de-novo acute myeloid leukaemia (AML) were entered into the Medical Research Council (MRC)'s 8th AML trial. All received the same induction therapy consisting of daunorubicin, cytarabine, and 6-thioguanine—DAT (1+5). The 67% who entered complete remission were randomised to consolidation with two or six further courses of DAT. Adults under the age of 55 were randomised for central nervous system (CNS) prophylaxis with intrathecal cytarabine and methotrexate. Finally, those still in remission after 1 year of cytarabine and 6-thioguanine (AT) maintenance were randomised to receive either late intensification with cyclophosphamide, vincristine, cytarabine, and prednisolone (COAP) or continued AT. The median survival for the whole group was 12 months; the median duration of first remission was 15 months, with relapse-free survival at 5 years estimated at 18%. The factors most strongly associated with poor survival were performance status and age at presentation, but even among those over 60 years of age, half went into remission. Six courses of DAT consolidation gave a small advantage over two courses in reducing the number of late relapses but no significant survival advantage. Late intensification showed a marginally significant advantage over continued AT maintenance. The incidence of CNS relapse was low and unaffected by prophylaxis. The second remission rate varied from 10% when the first remission was shorter than 6 months to 61% when it had continued for more than 2 years. 40 patients received histocompatible allogeneic bone-marrow transplants in first remission. There was a high procedure-related death rate, particularly among patients over 30 years of age. Thus, initially at least, the transplanted group had shorter survival than a comparaable group of chemotherapy-treated patients. Treatment specifications remained unchanged throughout the trial but those enrolled in the later half of the trial had a better (p = 0·003) survival." @default.
• W2000838340 created "2016-06-24" @default.
• W2000838340 creator A5001432477 @default.
• W2000838340 creator A5005887947 @default.
• W2000838340 creator A5008050165 @default.
• W2000838340 creator A5091832279 @default.
• W2000838340 date "1986-11-01" @default.
• W2000838340 modified "2023-10-18" @default.
• W2000838340 title "PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIAL" @default.
• W2000838340 cites W1255825804 @default.
• W2000838340 cites W1512380148 @default.
• W2000838340 cites W1529957398 @default.
• W2000838340 cites W1605880824 @default.
• W2000838340 cites W1757201400 @default.
• W2000838340 cites W1965044410 @default.
• W2000838340 cites W1970779268 @default.
• W2000838340 cites W1979005423 @default.
• W2000838340 cites W1979123982 @default.
• W2000838340 cites W2011474926 @default.
• W2000838340 cites W2020548865 @default.
• W2000838340 cites W2034641358 @default.
• W2000838340 cites W2038252730 @default.
• W2000838340 cites W2067131989 @default.
• W2000838340 cites W207118996 @default.
• W2000838340 cites W2093235670 @default.
• W2000838340 cites W2106249380 @default.
• W2000838340 cites W2161037099 @default.
• W2000838340 cites W2252759819 @default.
• W2000838340 cites W2278220001 @default.
• W2000838340 cites W2340895045 @default.
• W2000838340 cites W2342060162 @default.
• W2000838340 cites W2412945437 @default.
• W2000838340 cites W77764924 @default.
• W2000838340 cites W8717994 @default.
• W2000838340 doi "https://doi.org/10.1016/s0140-6736(86)92674-7" @default.
• W2000838340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2878130" @default.
• W2000838340 hasPublicationYear "1986" @default.
• W2000838340 type Work @default.
• W2000838340 sameAs 2000838340 @default.
• W2000838340 citedByCount "306" @default.
• W2000838340 countsByYear W20008383402012 @default.
• W2000838340 countsByYear W20008383402013 @default.
• W2000838340 countsByYear W20008383402014 @default.
• W2000838340 countsByYear W20008383402015 @default.
• W2000838340 countsByYear W20008383402016 @default.
• W2000838340 countsByYear W20008383402017 @default.
• W2000838340 countsByYear W20008383402018 @default.
• W2000838340 countsByYear W20008383402019 @default.
• W2000838340 countsByYear W20008383402020 @default.
• W2000838340 countsByYear W20008383402021 @default.
• W2000838340 countsByYear W20008383402022 @default.
• W2000838340 countsByYear W20008383402023 @default.
• W2000838340 crossrefType "journal-article" @default.
• W2000838340 hasAuthorship W2000838340A5001432477 @default.
• W2000838340 hasAuthorship W2000838340A5005887947 @default.
• W2000838340 hasAuthorship W2000838340A5008050165 @default.
• W2000838340 hasAuthorship W2000838340A5091832279 @default.
• W2000838340 hasConcept C120665830 @default.
• W2000838340 hasConcept C121332964 @default.
• W2000838340 hasConcept C126322002 @default.
• W2000838340 hasConcept C141071460 @default.
• W2000838340 hasConcept C187212893 @default.
• W2000838340 hasConcept C2776694085 @default.
• W2000838340 hasConcept C2776715498 @default.
• W2000838340 hasConcept C2776755627 @default.
• W2000838340 hasConcept C2778041864 @default.
• W2000838340 hasConcept C2778461978 @default.
• W2000838340 hasConcept C2778720950 @default.
• W2000838340 hasConcept C2779429289 @default.
• W2000838340 hasConcept C2781059491 @default.
• W2000838340 hasConcept C61511704 @default.
• W2000838340 hasConcept C71924100 @default.
• W2000838340 hasConceptScore W2000838340C120665830 @default.
• W2000838340 hasConceptScore W2000838340C121332964 @default.
• W2000838340 hasConceptScore W2000838340C126322002 @default.
• W2000838340 hasConceptScore W2000838340C141071460 @default.
• W2000838340 hasConceptScore W2000838340C187212893 @default.
• W2000838340 hasConceptScore W2000838340C2776694085 @default.
• W2000838340 hasConceptScore W2000838340C2776715498 @default.
• W2000838340 hasConceptScore W2000838340C2776755627 @default.
• W2000838340 hasConceptScore W2000838340C2778041864 @default.
• W2000838340 hasConceptScore W2000838340C2778461978 @default.
• W2000838340 hasConceptScore W2000838340C2778720950 @default.
• W2000838340 hasConceptScore W2000838340C2779429289 @default.
• W2000838340 hasConceptScore W2000838340C2781059491 @default.
• W2000838340 hasConceptScore W2000838340C61511704 @default.
• W2000838340 hasConceptScore W2000838340C71924100 @default.
• W2000838340 hasIssue "8518" @default.
• W2000838340 hasLocation W20008383401 @default.
• W2000838340 hasLocation W20008383402 @default.
• W2000838340 hasOpenAccess W2000838340 @default.
• W2000838340 hasPrimaryLocation W20008383401 @default.
• W2000838340 hasRelatedWork W1970500233 @default.
• W2000838340 hasRelatedWork W2017740060 @default.
• W2000838340 hasRelatedWork W2030243370 @default.
• W2000838340 hasRelatedWork W2058531229 @default.
• W2000838340 hasRelatedWork W2158711539 @default.
• W2000838340 hasRelatedWork W2252583337 @default.

• next